Head-to-head · WeighScore
Jently vs Queen RX
The verdict
Jently takes it — 67/100 to 66/100, but only just.
Jently grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jently is a clinician-guided telehealth service offering compounded GLP-1 weight management (semaglutide from $149/mo, tirzepatide from $199/mo) alongside NAD+, peptide therapy (sermorelin, glutathione),… Queen RX is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Jently | Queen RX |
|---|---|---|
| WeighScore | 67/100 | 66/100 |
| Grade | C | C |
| Scorecard rank | #178 | #212 |
| Semaglutide | $149/mo (starting dose, compounded) | $100/mo (quarterly plan, compounded) |
| Tirzepatide | $199/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | 45 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #178 · C
Strengths
- Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
- Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
- 100% online with licensed providers via the MD Integrations network
- Subscription can be cancelled anytime through the patient portal
Where it loses points
- Specific pharmacy partner not named on the site
- No refunds once a consultation is completed or a prescription is dispensed
- Not LegitScript-certified (no certification displayed)
- States of operation not published
Graded #212 · C
Strengths
- $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
- Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
- 45-state coverage
Where it loses points
- No LegitScript or PCAB accreditation
- No legal entity name or address disclosed
- No named pharmacy partners
- Not available in KS, LA, MS, NM, WV
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.